COSCIENS Biopharma (CSCI) Total Expenses

Annual Total Expenses

$22.51 M
+$1.61 M+7.72%

December 1, 2023

Summary

Performance

1-Year Change

+7.72%

3-Year Change

+131.64%

5-Year Change

+32.09%

15-Year Change

-6.21%

CSCI Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.66%
CSCI annual total expenses is higher than 21.66% of companies in Healthcare sector

High & Low

All-time High

$128.03 M
CSCI annual total expenses is currently -82.42% below its historical high of $128.03 million

3-Year Low

$13.93 M
CSCI annual total expenses is currently +61.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Annual Interest Expense

$96.60 K
CSCI annual interest expense is $96.60 thousand

Annual Income Tax

-$900.60 K
CSCI annual income tax is -$900.60 thousand

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

Quarterly Total Expenses

$6.71 M
+$613.00 K+10.06%

September 1, 2024

Summary

Performance

3-Month Change

+10.06%

1-Year Change

+94.06%

3-Year Change

+94.06%

5-Year Change

+94.06%

CSCI Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.03%
CSCI quarterly total expenses is higher than 26.03% of companies in Healthcare sector

High & Low

All-time High

$6.71 M
CSCI quarterly total expenses is currently at an all-time high

3-Year Low

$2.02 M
CSCI quarterly total expenses is currently +231.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Quarterly Interest Expense

$22.00 K
CSCI quarterly interest expense is $22.00 thousand

Quarterly Income Tax

-$112.00 K
CSCI quarterly income tax is -$112.00 thousand

Quarterly Operating Expenses

$5.79 M
CSCI quarterly total operating expenses is $5.79 million

Quarterly Cost Of Goods Sold

$914.00 K
CSCI quarterly cost of goods sold is $914.00 thousand

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$22.51 M
CSCI annual total expenses is $22.51 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

CSCI Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.7%+94.1%
3 y3 years+131.6%+94.1%
5 y5 years+32.1%+94.1%

CSCI Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+61.5%at high+232.0%
5 y5-yearat high+131.6%at high+232.0%
alltimeall time-82.4%+460.8%at high+4960.4%

COSCIENS Biopharma Total Expenses History

DateAnnualQuarterly
Sep 2024
-
$6.71 M(+10.1%)
Jun 2024
-
$6.09 M(+57.6%)
Mar 2024
-
$3.86 M(+11.9%)
Dec 2023
$22.51 M(+7.7%)
$3.46 M(+12.8%)
Sep 2023
-
$3.06 M(+22.2%)
Jun 2023
-
$2.51 M(-15.1%)
Mar 2023
-
$2.95 M(+6.3%)
Dec 2022
$20.89 M(+50.0%)
$2.78 M(+37.5%)
Sep 2022
-
$2.02 M(-21.1%)
Jun 2022
-
$2.56 M(-10.9%)
Mar 2022
-
$2.87 M(+41.3%)
Dec 2021
$13.93 M(+43.4%)
$2.03 M(-30.8%)
Sep 2021
-
$2.94 M(+2.1%)
Jun 2021
-
$2.88 M(-8.8%)
Mar 2021
-
$3.16 M(+15.8%)
Dec 2020
$9.72 M(-3.6%)
$2.73 M(+17.9%)
Sep 2020
-
$2.31 M(-5.6%)
Jun 2020
-
$2.45 M(+4.8%)
Mar 2020
-
$2.34 M(-13.2%)
Dec 2019
$10.08 M(-40.9%)
$2.70 M(+20.7%)
Sep 2019
-
$2.23 M(-13.2%)
Jun 2019
-
$2.57 M(-1.3%)
Mar 2019
-
$2.61 M(+11.1%)
Dec 2018
$17.04 M(-29.0%)
$2.35 M(+41.9%)
Sep 2018
-
$1.65 M(-17.4%)
Jun 2018
-
$2.00 M(+13.9%)
Mar 2018
-
$1.76 M(-49.4%)
Dec 2017
$24.00 M(-21.0%)
$3.48 M(+56.8%)
Sep 2017
-
$2.22 M(+34.2%)
Jun 2017
-
$1.65 M(-24.4%)
Mar 2017
-
$2.18 M(+71.0%)
Dec 2016
$30.39 M(-14.2%)
$1.28 M(-12.5%)
Sep 2016
-
$1.46 M(+7.6%)
Jun 2016
-
$1.36 M(-19.8%)
Mar 2016
-
$1.69 M(+72.3%)
Dec 2015
$35.43 M(-5.3%)
$980.80 K(-29.2%)
Sep 2015
-
$1.39 M(+10.2%)
Jun 2015
-
$1.26 M(-13.1%)
Mar 2015
-
$1.45 M(+0.2%)
Dec 2014
$37.41 M(+11.2%)
$1.44 M(-2.2%)
Sep 2014
-
$1.48 M(-4.3%)
Jun 2014
-
$1.54 M(+10.5%)
Mar 2014
-
$1.40 M(+10.2%)
Dec 2013
$33.65 M(+5.9%)
$1.27 M(-25.6%)
Sep 2013
-
$1.70 M(+56.8%)
Jun 2013
-
$1.09 M(-29.1%)
Mar 2013
-
$1.53 M(+10.7%)
Dec 2012
$31.79 M(-12.7%)
$1.38 M(-0.6%)
Sep 2012
-
$1.39 M(-13.1%)
Jun 2012
-
$1.60 M(+39.4%)
Mar 2012
-
$1.15 M(-12.7%)
Dec 2011
$36.41 M(-30.7%)
$1.32 M(-13.1%)
Sep 2011
-
$1.51 M(+42.1%)
Jun 2011
-
$1.07 M(-8.7%)
Mar 2011
-
$1.17 M(-25.3%)
Dec 2010
$52.51 M
$1.56 M(+3.3%)
DateAnnualQuarterly
Sep 2010
-
$1.51 M(+54.4%)
Jun 2010
-
$978.20 K(-13.0%)
Mar 2010
-
$1.12 M(+32.7%)
Dec 2009
$87.19 M(-13.6%)
$847.40 K(-18.4%)
Sep 2009
-
$1.04 M(+23.5%)
Jun 2009
-
$841.30 K(-14.9%)
Mar 2009
-
$989.10 K(+93.6%)
Dec 2008
$100.86 M(+31.3%)
$510.80 K(-57.7%)
Sep 2008
-
$1.21 M(-30.8%)
Jun 2008
-
$1.74 M(+39.2%)
Mar 2008
-
$1.25 M(+17.9%)
Dec 2007
$76.82 M(+17.3%)
$1.06 M(+11.7%)
Sep 2007
-
$951.30 K(-8.8%)
Jun 2007
-
$1.04 M(+39.4%)
Mar 2007
-
$748.20 K(-14.4%)
Dec 2006
$65.50 M(+15.3%)
$873.60 K(+27.0%)
Sep 2006
-
$688.00 K(-7.7%)
Jun 2006
-
$745.40 K(-1.3%)
Mar 2006
-
$755.10 K(+108.1%)
Dec 2005
$56.79 M(+13.9%)
$362.80 K(-38.0%)
Sep 2005
-
$584.70 K(-27.1%)
Jun 2005
-
$801.70 K(+72.7%)
Mar 2005
-
$464.30 K(-5.7%)
Dec 2004
$49.85 M(-61.1%)
$492.60 K(-1.9%)
Sep 2004
-
$501.90 K(-20.2%)
Jun 2004
-
$628.70 K(+37.7%)
Mar 2004
-
$456.50 K(-7.7%)
Dec 2003
$128.03 M(+65.5%)
$494.70 K(+10.4%)
Sep 2003
-
$448.20 K(-15.3%)
Jun 2003
-
$529.10 K(+62.2%)
Mar 2003
-
$326.30 K(+24.7%)
Dec 2002
$77.35 M(+100.1%)
$261.70 K(-6.5%)
Sep 2002
-
$279.80 K(-10.1%)
Jun 2002
-
$311.30 K(+21.6%)
Mar 2002
-
$256.00 K(-19.8%)
Dec 2001
$38.65 M(+175.0%)
$319.20 K(+0.7%)
Sep 2001
-
$317.00 K(-6.8%)
Jun 2001
-
$340.00 K(+74.9%)
Mar 2001
-
$194.40 K(-31.8%)
Dec 2000
$14.05 M(+25.1%)
$285.20 K(-27.6%)
Sep 2000
-
$393.70 K(+94.4%)
Jun 2000
-
$202.50 K(-1.9%)
Mar 2000
-
$206.50 K(-41.6%)
Dec 1999
$11.24 M(+64.6%)
$353.80 K(+29.9%)
Sep 1999
-
$272.40 K(+33.9%)
Jun 1999
-
$203.50 K(+53.6%)
Mar 1999
-
$132.50 K(-70.4%)
Dec 1998
$6.82 M(+22.1%)
$447.70 K(+127.8%)
Sep 1998
-
$196.50 K(-51.9%)
Jun 1998
-
$408.40 K(+44.9%)
Mar 1998
-
$281.80 K(-87.6%)
Dec 1997
$5.59 M(+39.3%)
$2.28 M(+43.2%)
Sep 1997
-
$1.59 M(-4.4%)
Jun 1997
-
$1.67 M(+4.5%)
Mar 1997
-
$1.59 M
Dec 1996
$4.01 M
-

FAQ

  • What is COSCIENS Biopharma annual total expenses?
  • What is the all time high annual total expenses for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual total expenses year-on-year change?
  • What is COSCIENS Biopharma quarterly total expenses?
  • What is the all time high quarterly total expenses for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly total expenses year-on-year change?

What is COSCIENS Biopharma annual total expenses?

The current annual total expenses of CSCI is $22.51 M

What is the all time high annual total expenses for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual total expenses is $128.03 M

What is COSCIENS Biopharma annual total expenses year-on-year change?

Over the past year, CSCI annual total expenses has changed by +$1.61 M (+7.72%)

What is COSCIENS Biopharma quarterly total expenses?

The current quarterly total expenses of CSCI is $6.71 M

What is the all time high quarterly total expenses for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly total expenses is $6.71 M

What is COSCIENS Biopharma quarterly total expenses year-on-year change?

Over the past year, CSCI quarterly total expenses has changed by +$3.25 M (+94.06%)